Cargando…
Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy
Acute myeloid leukemia (AML) is a heterogeneous disease in clinical presentation, outcome and therapeutic response. Cytogenetic and molecular characteristics are important prognostic indicators allowing the identification of distinct subtypes of AML, prognostic stratification and risk-adapted treatm...
Autores principales: | Coles, EC, Colita, A, Momanu, R, Berbec, N, Ivanescu, AM, Oprea, M, Jardan, D, Jardan, C, Arghir, A, Coriu, D, Lupu, AR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880215/ https://www.ncbi.nlm.nih.gov/pubmed/31803284 |
Ejemplares similares
-
Etiopathogenesis and prognostic implications of autoimmune hemolytic anemia association with chronic lymphocytic leukemia B
por: Oprea, MM, et al.
Publicado: (2012) -
Prognosis Factors in Chronic Lymphocytic Leukemia
por: Ivanescu, AM, et al.
Publicado: (2012) -
The impact of additional cytogenetic abnormalities at
diagnosis and during therapy with tyrosine kinase
inhibitors in Chronic Myeloid Leukaemia
por: Crisan, AM, et al.
Publicado: (2015) -
The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression – an overlapping myeloproliferative disorder or two distinct diseases? - case report
por: Ursuleac, I, et al.
Publicado: (2013) -
The simultaneous occurrence of multiple myeloma and JAK2 positive myeloproliferative neoplasms - Report on two cases
por: Badelita, S, et al.
Publicado: (2015)